BioSpace News Archive

Policy

Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio

Mayne Pharma Group Limited (“Mayne Pharma”) (ASX: MYX) has acquired the FDA approved halobetasol propionate foam 0.05% for an investment of up to US$32 million and an ongoing earn out payment

October 26, 2018
·
7 min read
Advicenne Wins Prestigious Prix Galien - Medstartup Award for Best Innovative Trial Design Leading to Quicker and Better Therapeutic Outcomes

Award recognizes ADV7103 in development for the treatment of distal Renal Tubular Acidosis (dRTA)

October 26, 2018
·
5 min read
Inositec’s INS-3001 Significantly Reduces Vascular Calcification Data Presented at Kidney Week 2018 Indicates

Inositec announced today that INS-3001, a novel vascular calcification inhibitor, demonstrated the ability to significantly inhibit the calcification process in preclinical studies.

October 26, 2018
·
3 min read
Business

Takeda Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc

Significant Milestone in Proposed Acquisition of Shire

October 26, 2018
·
9 min read
Business

Targovax ASA: Announcement of Third Quarter 2018 Financial Results

Targovax ASA will announce its third quarter 2018 results on Thursday, 1 November 2018 at 07:00 CET.

October 26, 2018
·
1 min read
Aachen-based Startup Company Protembis Successfully Closes $ 10 Million Series A Financing

The Managing Directors and founders of Protembis GmbH, Karl von Mangoldt and Conrad Rasmus, have successfully closed a Series A financing round in a structured process.

October 26, 2018
·
4 min read
Business

Alligator Bioscience AB Interim Report January-September 2018

The science behind the Nobel Prizes in Medicine and Chemistry constitutes the core in Alligator’s research and development.

October 26, 2018
·
3 min read
Business

Medivir AB - Interim Report January - September 2018

Increased focus where we can create the most value

October 26, 2018
·
6 min read
Drug Development

Nordic Nanovector Announces Opening of First US Site for PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma

Nordic Nanovector ASA announces that the first clinical site in the United States (in Long Beach, CA) for the pivotal PARADIGME trial has been initiated to enable enrolment of patients.

October 26, 2018
·
4 min read
Drug Development

Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development

Proceeds to fund Phase 2/3 trial of inhaled TD139 in idiopathic pulmonary fibrosis (IPF) and advancement of oral and ocular pipeline candidates into clinical studies

October 26, 2018
·
4 min read